Delivery Order SPE2DB24D1107-SPE2DB24FZEA5
- Not listed
- This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,192.24 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 12, 2024. The contract has an ultimate completion date of July 15, 2024 and does not utilize any set-aside designations. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $2,384.96 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 5, 2024 and was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $9,590.46 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024 with a completion date of July 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing...
- This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,872.19 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 29, 2024, with a completion date of July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical valued at $999,999,999,...
- The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,144.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is set for April 22, 2024. The contract does not have a set-aside designation, indicating open...
- The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $5,614.33 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 13, 2024, with a completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This federal contract award is for the provision of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceuticals to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $26,320.17 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 17, 2024 and does not have a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA), a defense agency. The $1,784.22 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of June 17, 2025 and is not a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,385.99 with a firm fixed price. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply ADVAIR HFA 230-21 MCG INHALER 12GM to the agency. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $22,213.91 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 1, 2024 and was awarded on April 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB24FZEA5Delivery Order
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,692.62 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 22, 2024 with an ultimate completion date of April 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen's expertise in pharmaceutical distribution enables it to efficiently manage the logistics of supplying critical medical products to government agencies like the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 4/22/24 |